Table 5.
Bioactions of SPMs on micro-RNA regulation, demonstrated in non-CF models.
| micro-RNA | ||||
|---|---|---|---|---|
| Conditions | SPMs | Models | Bioactions | References |
| In vitro studies | ||||
| TNF-α treatment | LXA4 | Human umbilical vein endothelial cells | Up-regulates miR-126-5p (related to endothelial repair and VCAM-1 expression) | Codagnone et al., 2017 |
| TGF-β-induced fibrosis | LXA4 | Human renal epithelial HK-2 cells Human mesangial cells Rat renal NRK49F fibroblasts |
Up-regulates miR let-7c and reduces human renal fibrosis Decreases miR let-7c level in rat fibroblasts |
Brennan et al., 2013 |
| Other | RvD1 RvE1 RVD2 & PD1 |
Human peripheral blood mononuclear cells | Regulates miR-146b, miR-21, miR-208 and miR-219-5p Regulates miR-219-5p and miR-21 but not miR146b Regulate miR-146b and miR-21 but not miR-219-5p |
Fredman et al., 2012 |
| In vivo studies | ||||
| Chronic renal fibrosis | LXA4 | Male wistar rats | Up-regulates miR let-7c and reduces renal fibrosis | Brennan et al., 2013 |
| Acute peritonitis | RvD1 analog | Male FVB mice | Temporally controls miRNAs, increases miR21 and miR146b, decreases miR208a (NF-kB signaling) and miR219 (LTB4 production) | Recchiuti et al., 2011 |